The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Name:	us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Consortium Agreement - Narrative (Detail)	1 Months Ended		3 Months Ended
Consortium Agreement - Narrative (Detail)	Aug. 31, 2018 USD ($) investors	Dec. 31, 2016 USD ($) investors	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Company received amount from agreement		$ 500,000
Invested amount for research and development	$ 1,500,000
Other income			$ 0	$ 0
Consortium Agreement \| Legacy Origin Series C Investor
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Company received amount from agreement			$ 0
Consortium Agreement \| Legacy Origin Series B Preferred Stock
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of investors \| investors	2	2